Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

NCT04435964 · clinicaltrials.gov ↗

COMPLETED

Status

247

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Lung Cancer
Head and Neck Cancer
Urogenital Neoplasms
Breast Cancer

Interventions

DRUG: Immunotherapy

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators

[object Object]
[object Object]
[object Object]